Falguni Patel is with Tanvex Biopharma USA, Inc. in San Diego, California.
Analysis of Therapeutic Monoclonal Antibodies Using a Platform Size Exclusion-HPLC Method
In biotherapeutics manufacturing, controlling size variants of therapeutic monoclonal antibodies (mAbs) is critical for ensuring product quality.